A recent study of San Francisco Bay Area physicians reports on successful intervention techniques for victims of domestic violence.

A team of scientists at the University of California, San Francisco and Compugen, Ltd. has discovered a new molecule of the immune system -- a member of a family of proteins called chemokines which recruit the body's army of defensive immune cells to sites of invasion.

University of California San Francisco researchers may have discovered why the experimental anti-cancer drug Onyx-015 works more broadly than had been expected...

Cardiopulmonary (CPR) training can relieve stress for parents and improve survival outcomes for infants at high risk for cardiopulmonary arrest, a new study has found.

A team led by a University of California, San Francisco scientist has developed drug-like inhibitors to study vital signaling molecules essential for almost all cell activity.

Jeffrey A. Bluestone, PhD, one of the world's leading experts on why the body's immune system rejects or tolerates transplanted tissue, has been appointed to a new professorship at the University of California, San Francisco devoted to diabetes research.

A new $50 million dollar research program launched this month will begin the daunting task of mapping out the thousands of molecular interactions that cells use in responding to their environment.

The new optimism expressed by healthcare providers treating HIV seropositive patients is mitigated by concerns surrounding treatment decisions and skepticism about the future according to a new University of California, San Francisco study.